Effects of Mahaenggamseok-tang-gagambang on Immune Cells and Cytokines in OVA-Induced Asthmatic Mice

마행감석양가감방(麻杏甘石揚加減方)이 천식모델생쥐의 면역세포 및 사이토카인에 미치는 영향

  • Park, Gil-Byeong (Division of Respiratory System, Department of Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Park, Yang-Chun (Division of Respiratory System, Department of Internal Medicine, College of Oriental Medicine, Daejeon University)
  • 박길병 (대전대학교 한의과대학 폐계내과학교실) ;
  • 박양춘 (대전대학교 한의과대학 폐계내과학교실)
  • Published : 2009.06.25

Abstract

The purpose of this research is to evaluate the effect of Mahaenggamseok-tang-gagambang (MGTG) on airway hyper- responsiveness (AHR), immune cells, cytokines and lung tissue in OVA-induced asthmatic mice. C578L/6 mice were injected, inhaled and sprayed with OVA for 12 weeks (3times a week) for asthma sensitization and challenge. Two experimental groups were treated with different concentrations of MGTG (400 mg/kg and 200 mg/kg) extract and cyclosporin A (10 mg/kg) for the later 8 weeks. Enhanced pause (Penh) levels were measured by whole body plethysmography. Immune cells were analyzed by flow cytometer in peripheral blood monocyte cell (PBMC) and lung cells. The IL-1b, IL-12, IFN-${\gamma}$, OVA-lgE, IL-4, IL-5, TNF-${\alpha}$ were analyzed by ELISA kit in serum and splenocyte+a-cCDS/a-CD28. Enhanced pause (Penh) levels of the MGTG groups (400 mg/kg and 200 mg/kg) were decreased significantly compared with that of control group. The numbers of MGTG groups (400 mg/kg and 200 mg/kg) on lung total cells were decreased significantly compared with that of control group. The numbers of MGTG groups (400 mg/kg and 200 mg/kg) on $CD3^+/CD69^+$, $B220^+/CD22^+$, $B220^+/CD23^+$, $B220^+/lgE^+$, $CCR3^+$ cells were decreased significantly compared with that of control group. The number of MGTG group (400 mg/kg) on $CD3^+/CD49b^+$ cells was decreased significantly compared with that of control group. The level of MGTG groups (400 mg/kg and 200 mg/kg) on IL-4, IL-5, IL-12, TNF-${\alpha}$, OVA-lgE were decreased significantly compared with that of control group. The level of MGTG group (400 mg/kg) on IL-1b, IL-1S, OVA-lgE were decreased significantly compared with that of control group. These results demonstrate that MGTG could be a desirable alternative therapy for allergic asthma by inhibiting the expression of immune cells, the activation of inflammatory mediator.

Keywords

References

  1. 홍천수, 김규언. 기관지천식-병인 및 역학, 대한 천식 및 알레르기학회, 천식과 알레르기 질환, 서울, 군자출판사, pp 244-245, 2002
  2. Korean Academy of Tuberculosis and Respiratory Disease. Guideline of chronic obstructive pulmonary disease (COPD) and asthma. Available at: www.lungkorea.com
  3. 전국한의과대학 폐계내과학교실. 東醫肺系內科學. 서울, 한문화사, pp 329-331, 2002
  4. Muro, S., Minshal, E.M., Hamid, Q.A. The pathology of chronic asthma. Clin Chest Med 21(2):225-244, 2002
  5. Fang, S.P., Tanaka, T., Tago, F., Okamoto, T., Kojima, S. Immunomodulatory effects of gyokuheifusan on INF-gamma/IL-4 (Th1/Th2) balance in ovalbumin (OVA)-induced asthma model mice. Biol Pharm Bull 28(5):829-833, 2005 https://doi.org/10.1248/bpb.28.829
  6. Nagai, T., Arai, Y., Emori, M., Nunome, S.Y., Yabe, T., Takeda, T., Yamada, H. Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model. Int Immunopharmacol. 4(10-11):1353-1365, 2004 https://doi.org/10.1016/j.intimp.2004.05.021
  7. 張機. 傷寒雜病論. 석가장, 하북과학기술출판사, pp 35-36, 1994
  8. 홍남두, 정규만, 문정호, 주수만. 생약 복합 제제의 약효 연구 -마행감석탕이 진통, 해열, 소염, 거담, 적출장관 및 혈압과 호흡에 미치는 영향-. 생약학회지 17(3):223-231, 1986
  9. 이주희, 정승기, 이형구. 마황행인감초석고탕 및 마황행인감초석고탕가미방이 $SO_₂$에 의한 흰쥐의 호흡기손상에 미치는 영향. 경희한의대논문집, 16: 85-105, 1993
  10. 박상현, 정희재, 정승기, 이형구. 마행감석탕과 길경이 인간기관지 상피세포의 Cytokine에 미치는 영향. 경희의학, 17(2):230-241, 2001
  11. Finotto, S., De Sanctis, G.T., Lehr, H.A., Herz, U., Buerke, M., Schipp, M., Bartsch, B., Atreya, R., Schmitt, E., Galle, P.R., Renz, H., Neurath, M.F. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med 193(11):1247-1260, 2001 https://doi.org/10.1084/jem.193.11.1247
  12. Braman, S.S. The global burden of asthma. Chest 130(1 Suppl):4S-12S, 2006 https://doi.org/10.1378/chest.130.1_suppl.4S
  13. 건강보험심사평가원. 2006년 건강보험통계지표. http://www.hira.or.kr/cms/rg/rgc/pds_02/1186060_1278.html
  14. Cho, S.H., Park, H.W., Rosenberg, D.M. The current status of asthma in Korea. J Korean Med Sci 21(2):181-187, 2006 https://doi.org/10.3346/jkms.2006.21.2.181
  15. 최병휘. 천식의 병인. 대한결핵 및 호흡기학회. 호흡기학. 서울, 군자출판사, pp 317-347, 2004
  16. Haley, K.J., Sunday, M.E., Wiggs, B.R., Kozakewich, H.P., Reilly, J.J., Mentzer, S.J., Sugarbaker, D.J., Doerschuk, C.M., Drazen, J.M. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 158(2):565-572, 1998 https://doi.org/10.1164/ajrccm.158.2.9705036
  17. 이상엽, 인광호. 천식의 면역학적 기전. 결핵 및 호흡기질환. 60(4):1-12, 2006
  18. Schwartz, R.S. A new element in the mechanism of asthma. N Engl J Med 346(11):857-858, 2002 https://doi.org/10.1056/NEJM200203143461114
  19. Siraganian, R.P. Biochemical events in basophil or mast cell activation and mediator release. In: Middleton, E. Jr, Reed, C.E., Ellis, E.F., Adkinson, N.F. Jr, Yunginger, J.W., Busse, W.W. editors. Allergy: principles & practice. 5th ed. St. Luis, Mosby-Year Book, pp 204-227, 1998
  20. Lane, S.J., Lee, T.H. Mast cell effector mechanism. J Allergy Clin Immunol 98(5 Pt 2):S67-72, 1996 https://doi.org/10.1016/S0091-6749(96)70019-2
  21. 이양근. 호산구와 천식. 결핵 및 호흡기질환, 46(1):5-16, 1999
  22. 안강모, 김미경, 조상헌, 박춘식, 이민걸. 알레르기 염증반응에 관여하는 세포. 대한 천식 및 알레르기학회. 천식과 알레르기 질환. 서울, 군자출판사, pp 34-38, 2002
  23. Spiteri, M.A., Knight, R.A., Jeremy, J.Y., Barnes, P.J., Chung, K.F. Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur Respir J 7(8):1431-1438, 1994
  24. Chung, K.F., Barnes, P.J. Cytokines in asthma. Thorax 54(9):825-857, 1999 https://doi.org/10.1136/thx.54.9.825
  25. Brewster, C.E., Howarth, P.H., Djukanovic, R., Wilson, J., Holgate, S.T., Roche, W.R. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 3(5):507-511, 1990 https://doi.org/10.1165/ajrcmb/3.5.507
  26. 전국한의과대학본초학교수. 본초학, 서울, 영림사, pp 178-179, 212-213, 294-295, 369-370, 373-374, 461-462, 478-479, 481-483, 485-486, 509-510, 1991
  27. Booth, B.W., Newcomb, D.C., McKane, S.A., Crews, A.L., Adler, K.B., Bonner, J.C., Martin, L.D. Proliferation of the airway epithelium in asthma: are inflammatory cells required? Chest 123(3 Suppl):384S-385S, 2003 https://doi.org/10.1378/chest.123.3_suppl.384S
  28. Hartnell, A., Robinson, D.S., Kay, A.B., Wardlaw, A.J. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 80(2):281-286, 1993
  29. Nitschke, L. The role of CD22 and other inhibitory co-receptors in B-cell activation. Curr Opin Immunol 17(3):290-297, 2005 https://doi.org/10.1016/j.coi.2005.03.005
  30. Harkins, M.S., Moseley, P.L., Iwamoto, G.K. Regulation of CD23 in the chronic inflammatory response in asthma: a role for interferon-gamma and heat shock protein 70 in the TH2 environment. Ann Allergy Asthma Immunol 91(6):567-574, 2003 https://doi.org/10.1016/S1081-1206(10)61536-0
  31. 조상헌. IgE 항체 생성과 조절. 알레르기, 13: 460-464, 1993
  32. 김태윤. 알레르기 염증반응에서 사이토카인과 케모카인. 대한 천식 및 알레르기학회. 천식과 알레르기 질환. 서울, 군자출판사, pp 55-58, 2002
  33. rin, E.M., Williams, T.J., Barnes, P.J., Hansel, T.T. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. Curr Drug Targets Inflamm Allergy 1(2):201-214, 2002 https://doi.org/10.2174/1568010023344715
  34. 양은석. 천식에서 IL-4/IL-13 사이토카인 및 수용체. 소아알레르기 및 호흡기학회지 15(1):1-11, 2005
  35. Greenfeder, S., Umland, S.P., Cuss, F.M., Chapman, R.W., Egan, R.W. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res 2(2):71-79, 2001 https://doi.org/10.1186/rr41
  36. 송소향, 김관형, 문화식, 송정섭, 박성학. 호산구의 혈관내피세포 접착에 대한 IL-13의 영향. 천식 및 알레르기, 19(1):31-41, 1999
  37. Thomas, P.S. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol 79(2):132-140, 2001 https://doi.org/10.1046/j.1440-1711.2001.00980.x
  38. Lappalainen, U., Whitsett, J.A., Wert, S.E., Tichelaar, J.W., Bry, K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 32(4):311-318, 2005 https://doi.org/10.1165/rcmb.2004-0309OC
  39. Meyts, I., Hellings, P.W., Hens, G., Vanaudenaerde, B.M., Verbinnen, B., Heremans, H., Matthys, P., Bullens, D.M., Overbergh, L., Mathieu, C., De Boeck, K., Ceuppens, J.L. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J Immunol 177(9):6460-6470, 2006 https://doi.org/10.4049/jimmunol.177.9.6460